biote Corp banner
B

biote Corp
NASDAQ:BTMD

Watchlist Manager
biote Corp
NASDAQ:BTMD
Watchlist
Price: 2.22 USD -0.89% Market Closed
Market Cap: $87.8m

biote Corp
Total Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

biote Corp
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
b
biote Corp
NASDAQ:BTMD
Total Liabilities
$166.2m
CAGR 3-Years
2%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Liabilities
$117.7B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
6%
Bristol-Myers Squibb Co
NYSE:BMY
Total Liabilities
$71.6B
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Total Liabilities
$121.7B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Total Liabilities
$84.3B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Total Liabilities
$85.9B
CAGR 3-Years
30%
CAGR 5-Years
16%
CAGR 10-Years
15%
No Stocks Found

biote Corp
Glance View

Market Cap
87.8m USD
Industry
Pharmaceuticals

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas. The company went IPO on 2021-03-02. The firm provides components to enable Biote-certified practitioners to establish, build, and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. Its Biote Method is a comprehensive, end-to-end practice-building platform that provides Biote-certified practitioners with components specifically developed for practitioners in the hormone optimization space, such as Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The firm trains practitioners how to identify and treat early indicators of hormone-related aging conditions. The company also sells a complementary Biote-branded line of dietary supplements.

BTMD Intrinsic Value
11.72 USD
Undervaluation 81%
Intrinsic Value
Price $2.22
B

See Also

What is biote Corp's Total Liabilities?
Total Liabilities
166.2m USD

Based on the financial report for Dec 31, 2025, biote Corp's Total Liabilities amounts to 166.2m USD.

What is biote Corp's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
27%

Over the last year, the Total Liabilities growth was -27%. The average annual Total Liabilities growth rates for biote Corp have been 2% over the past three years , 27% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett